Author

Y. Rombouts

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

A. Boyance· 1 shared A. Coste· 1 shared A. Hessel· 1 shared A. Metais· 1 shared A.-F. Tilkin-Mariame· 1 shared C. Berrone· 1 shared C. Cougoule· 1 shared C. Devaud· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Boyance

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Phospholipid peroxidation fuels ExoU phospholipase-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology

S. Bagayoko, S.-A. Leon-Icaza, M. Pinilla, A. Hessel, K. Santoni, P.-J. Bordignon, F. Moreau, E. Eren, A. Boyance, E. Naser, L. Lefevre, C. Berrone, N. Iacobachvili, A. Metais, Y. Rombouts, , E. Meunier

This study identifies phospholipid peroxidation as a mechanism enhancing ExoU phospholipase activity, leading to cell necrosis and supporting Pseudomonas aeruginosa pathogenesis.

bioRxiv · Feb 17, 2021Immunology

Colon-specific immune microenvironment regulates cancer progression versus rejection

G. Trimaglio, A.-F. Tilkin-Mariame, V. Feliu, F. Lauzeral-Vizcaino, M. Tosolini, C. Valle, M. Ayyoub, O. Neyrolles, N. Vergnolle, Y. Rombouts, C. Devaud

This study shows that the colon microenvironment influences whether colorectal tumors progress or are rejected, with distinct immune signatures in each outcome.

bioRxiv · Jan 2, 2020Cancer Biology